P504S Monoclonal Antibody

This gene encodes a racemase. The encoded enzyme interconverts pristanoyl-CoA and C27-bile acylCoAs between their (R)- and (S)-stereoisomers. The conversion to the (S)-stereoisomers is necessary for degradation of these substrates by peroxisomal beta-oxidation. Encoded proteins from this locus localize to both mitochondria and peroxisomes. Mutations in this gene may be associated with adult-onset sensorimotor neuropathy, pigmentary retinopathy, and adrenomyeloneuropathy due to defects in bile acid synthesis. Alternatively spliced transcript variants have been described. Read-through transcription also exists between this gene and the upstream neighboring C1QTNF3 (C1q and tumor necrosis factor related protein 3) gene.

The P504S Monoclonal Antibody is a highly advanced and meticulously developed product that serves as an invaluable tool in the field of medical diagnostics. This antibody, derived from a hybridoma cell line, exhibits exceptional specificity and sensitivity in detecting the P504S protein, which is known to be overexpressed in certain types of cancer cells.

With its cutting-edge technology and rigorous quality control measures, this monoclonal antibody ensures accurate and reliable results, aiding healthcare professionals in the precise identification and characterization of cancerous tissues. Its exceptional performance and robustness make it an indispensable asset in the diagnosis, prognosis, and monitoring of various malignancies.

The P504S Monoclonal Antibody is designed to be used in immunohistochemistry applications, enabling the visualization and localization of the P504S protein within tissue samples. Its high affinity and selectivity allow for precise detection, even in samples with low expression levels, facilitating early detection and intervention.

This product adheres to the highest industry standards, ensuring consistent and reproducible results across different laboratories and settings. Its user-friendly nature and compatibility with various staining protocols make it accessible to a wide range of professionals, from seasoned pathologists to researchers and technicians.

In summary, the P504S Monoclonal Antibody represents a breakthrough in the field of medical diagnostics, providing an indispensable tool for accurate and efficient detection of P504S protein expression in cancerous tissues. Its exceptional specificity, sensitivity, and reliability make it an essential component in the fight against cancer, enabling early detection and improved patient outcomes.